Ms. Sharon Tetlow brings 30 years of financial leadership to DICE Therapeutics. She currently serves as boardmember and audit committee chair at Catalyst Biosciences (NASDAQ: CBIO) and as a supervisory board member and chair of the audit committee at Valneva SE (NASDAQ: VALN; Euronext Paris: VAL.PA). She has led Potrero Hill Advisors, a life-sciences focused provider of financial strategy and operational services since January 2016, and prior to Potrero was managing director of Danforth Advisors. For more than 15 years before that, Ms. Tetlow served as CFO of various biotech companies, both private and public. Ms. Tetlow was previously on the board of directors, audit committee and transaction committee of Armetheon, Inc., a privately held biotech company. Ms. Tetlow holds a B.A. in Psychology from University of Delaware and an M.B.A. from the GSB at Stanford University.